特发性颅内压增高

Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010;28:593-617.

• 全文
• 摘要

Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875-877.

• 摘要

Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50:78-80.

• 摘要

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311:1641-1651.

• 全文
• 摘要

Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol. 1988;45:866-872.

• 摘要

Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998 Dec;105(12):2313-7.

• 摘要

Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol. 1964 Oct;48:522-43.

• 全文
• 摘要

Wall M, Purvin V. Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology. 2009;72:300-301.

• 摘要

Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 Mar;5(1):55-6.

• 摘要

Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982 Jan;45(1):13-8.

• 全文
• 摘要

Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010 Jul 7;341:c2701.

• 全文
• 摘要

1.  Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010;28:593-617.

• 全文
• 摘要

2.  Shah VA, Kardon RH, Lee AG, et al. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology. 2008;70:634-640.

• 摘要

3.  Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875-877.

• 摘要

4.  Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50:78-80.

• 摘要

5.  Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999;52:870-872.

• 摘要

6.  Lueck C, McIlwaine G, Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database of Syst Rev. 2005;(3):CD003434.

• 全文
• 摘要

7.  Radhakrishnan K, Thacker AK, Bohlaga NH, et al. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993;116:18-28.

• 摘要

8.  NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311:1641-1651.

• 全文
• 摘要

9.  Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol. 1988;45:866-872.

• 摘要

10.  Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998 Dec;105(12):2313-7.

• 摘要

11.  Joynt RJ, Sahs AL. Brain swelling of unknown cause. Neurology. 1956 Nov;6(11):801-3.

• 摘要

12.  Wall M, Dollar JD, Sadun AA, et al. Idiopathic intracranial hypertension: lack of histologic evidence for cerebral edema. Arch Neurol. 1995 Feb;52(2):141-5.

• 摘要

13.  Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol. 1964 Oct;48:522-43.

• 全文
• 摘要

14.  Wall M, White WN 2nd. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998 Jan;39(1):134-42.

• 全文
• 摘要

15.  Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011;76:1564-1567.

• 摘要

16.  Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118:1626-1630.

• 摘要

17.  Wall M, Purvin V. Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology. 2009;72:300-301.

• 摘要

18.  Deonna T, Guignard JP. Acute intracranial hypertension after nalidixic acid administration. Arch Dis Child. 1974;49:743.

• 全文
• 摘要

19.  Mushet GR. Pseudotumor and nitrofurantoin therapy. Arch Neurol. 1977;34:257.

• 摘要

20.  Konomi H, Imai M, Nihei K, et al. Indomethacin causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med. 1978;298:855.

• 摘要

21.  Larizza D, Colombo A, Lorini R, et al. Ketoprofen causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med. 1979;300:796.

• 摘要

22.  Feldman MH, Schlezinger NS. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol. 1970;22:1-7.

• 摘要

23.  Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology. 1984;34:1509-1511.

• 摘要

24.  Colucciello M. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia. Arch Ophthalmol. 2003;121:1064-1065.

• 摘要

25.  Van Dop C, Conte FA, Koch TK, et al. Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N Engl J Med. 1983;308:1076-1080.

• 摘要

26.  Saul RF, Hamburger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. JAMA. 1985;253:2869-2870.

• 摘要

27.  Shah A, Roberts T, McQueen IN, et al. Danazol and benign intracranial hypertension. Br Med J. 1987;294:1323.

• 全文
• 摘要

28.  Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol. 1998;126:116-121.

• 摘要

29.  Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology. 1995;45:6-10.

• 摘要

30.  Keltner JL, Johnson CA, Cello KE, et al. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2014 Apr 29;55(5):3200-7.

• 全文
• 摘要

31.  Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985 Mar;5(1):55-6.

• 摘要

32.  Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982 Jan;45(1):13-8.

• 全文
• 摘要

33.  Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990 Dec;10(6):331-5.

• 摘要

34.  Friedman DI, Quiros PA, Subramanian PS, el al. Headache in idiopathic intracranial hypertension: Findings from the Idiopathic Intracranial Hypertension Treatment Trial. Headache. 2017 Sep;57(8):1195-1205.

• 摘要

35.  Giuseffi V, Wall M, Siegel PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991 Feb;41(2 ( Pt 1)):239-44.

• 摘要

36.  Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984 Oct;16(4):489-94.

• 摘要

37.  Bulens C, Meerwaldt JD, Koudstaal PJ, et al. Spatial contrast sensitivity in benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1988 Oct;51(10):1323-9.

• 全文
• 摘要

38.  Corbett JJ. The 1982 Silversides lecture: problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci. 1983 Nov;10(4):221-9.

• 摘要

39.  Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc. 1980 Sep;55(9):541-6.

• 摘要

40.  Wall M, Falardeau J, Fletcher WA, et al. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015 Sep 1;85(9):799-805.

• 摘要

41.  Meador KJ, Swift TR. Tinnitus from intracranial hypertension. Neurology. 1984 Sep;34(9):1258-61.

• 摘要

42.  Scott CJ, Kardon RH, Lee AG, et al. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010 Jun;128(6):705-11.

• 摘要

43.  Wall M, Thurtell MJ; NORDIC Idiopathic Intracranial Hypertension Study Group. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial. Br J Ophthalmol. 2017 Sep;101(9):1256-60.

• 摘要

44.  Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991 Feb;114 (pt 1A):155-80.

• 摘要

45.  NORDIC Idiopathic Intracranial Hypertension Study Group; Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014 Jun;71(6):693-701.

• 全文
• 摘要

46.  Wall M, Johnson CA, Cello KE, et al. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12.

• 全文
• 摘要

47.  Neville L, Egan RA. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol. 2005 Dec;40(6):775-7.

• 摘要

48.  Lim MJ, Lin JP. The effects of carbon dioxide on measuring cerebral spinal fluid pressure. Childs Nerv Syst. 2009 Jul;25(7):783-4.

• 摘要

49.  Bono F, Quattrone A. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2007 Apr 24;68(17):1439-40.

• 摘要

50.  Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983 Oct;33(10):1386-8.

• 摘要

51.  Whiteley W, Al-Shahi R, Warlow CP, et al. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2006 Nov 14;67(9):1690-1.

• 摘要

52.  Berdahl JP, Fleischman D, Zaydlarova J, et al. Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2012 Mar 15;53(3):1422-7.

• 全文
• 摘要

53.  Avery RA, Shah SS, Licht DJ, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010 Aug 26;363(9):891-3.

• 全文
• 摘要

54.  Batnitzky S, Keucher TR, Mealey J Jr, et al. Iatrogenic intraspinal epidermoid tumors. JAMA. 1977 Jan 10;237(2):148-50.

• 摘要

55.  Traviesa DC, Schwartzman RJ, Glaser JS, Savino P. Familial benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1976 May;39(5):420-3.

• 全文
• 摘要

56.  Sismanis A. Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management. Laryngoscope. 1987 Aug;97(8 Pt 2 Suppl 42):1-17.

• 摘要

57.  Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med. 1974 May;133(5):802-7.

• 摘要

58.  Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010 Jul 7;341:c2701.

• 全文
• 摘要

59.  Friedman DI, Streeten DH. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology. 1998 Apr;50(4):1099-104.

• 摘要

60.  Amaral JF, Tsiaris W, Morgan T, et al. Reversal of benign intracranial hypertension by surgically induced weight loss. Arch Surg. 1987 Aug;122(8):946-9.

• 摘要

61.  Sugerman HJ, Felton WL 3rd, Sismanis A, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999 May;229(5):634-40.

• 全文
• 摘要

62.  Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011 Jan;114(1):34-9.

• 摘要

63.  Lubow M, Kuhr L. Pseudotumor cerebri: comments on practical management. In: Glaser JS, Smith JL, eds. Neuro-ophthalmology, Vol. IX. St Louis, MO: CV Mosby; 1976:199-206.

64.  Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol. 1988;8:93-8.

65.  Lee AG, Anderson R, Kardon RH, Wall M. Presumed "sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? Am J Ophthalmol. 2004 Jul;138(1):114-8.

• 摘要

66.  Rubin RC, Henderson ES, Ommaya AK, et al. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg. 1966 Oct;25(4):430-6.

• 摘要

67.  McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther. 1974 Apr;189(1):194-201.

• 摘要

68.  Lichter PR. Reducing side effects of carbonic anhydrase inhibitors. Ophthalmology. 1981 Mar;88(3):266-9.

• 摘要

69.  Garner LL, Carl EF, Ferwerda JR. Advantages of sustained-release therapy with acetazolamide in glaucoma. Am J Ophthalmol. 1963;55:323-7.

70.  Zimran A, Beutler E. Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts? Am J Ophthalmol. 1987 Dec 15;104(6):654-8.

• 摘要

71.  ten Hove MW, Friedman DI, Patel AD, Irrcher I, et al; NORDIC Idiopathic Intracranial Hypertension Study Group. Safety and tolerability of acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016 Mar;36(1):13-9.

• 摘要

72.  Pollay M, Fullenwider C, Roberts PA, et al. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg. 1983 Dec;59(6):945-50.

• 摘要

73.  Roberts PA, Pollay M, Engles C, et al. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol. J Neurosurg. 1987 Mar;66(3):440-6.

• 摘要

74.  Vogh BP, Langham MR Jr. The effect of furosemide and bumetanide on cerebrospinal fluid formation. Brain Res. 1981 Sep 21;221(1):171-83.

• 摘要

75.  Buhrley LE, Reed DJ. The effect of furosemide on sodium-22 uptake into cerebrospinal fluid and brain. Exp Brain Res. 1972 Apr 27;14(5):503-10.

• 摘要

76.  Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994 Apr;9(2):130-4.

• 摘要

77.  Schoeman J, Donald P, van Zyl L, et al. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol. 1991 May;33(5):396-405.

• 摘要

78.  Celebisoy N, Gokcay F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007 Nov;116(5):322-7.

• 摘要

79.  European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication].

• 全文

80.  Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996 Jun;46(6):1524-30.

• 摘要

81.  Rosenberg M, Smith C, Beck R, et al. The efficacy of shunting procedures in pseudotumor cerebri (abstract). Neurology. 1989;39(suppl 1):S209.

82.  Johnston I, Besser M, Morgan MK. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg. 1988 Aug;69(2):195-202.

• 摘要

83.  Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997 Sep;49(3):734-9.

• 摘要

84.  McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004 Oct;101(4):627-32.

• 摘要

85.  Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol. 1997 Jun;17(2):86-91.

• 摘要

86.  Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1426-9.

• 全文
• 摘要

87.  Kelman SE, Heaps R, Wolf A, et al. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery. 1992 Mar;30(3):391-5.

• 摘要

88.  Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol. 1988 Oct;106(10):1384-90.

• 摘要

89.  Corbett JJ, Nerad JA, Tse DT, et al. Results of optic nerve sheath fenestration for pseudotumor cerebri: the lateral orbitotomy approach. Arch Ophthalmol. 1988 Oct;106(10):1391-7.

• 摘要

90.  Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993 May;100(5):683-90.

• 摘要

91.  Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1988 Oct;106(10):1378-83.

• 摘要

92.  Rizzo JF 3rd, Lessell S. Choroidal infarction after optic nerve sheath fenestration. Ophthalmology. 1994 Sep;101(9):1622-6.

• 摘要

93.  Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993 May;111(5):632-5.

• 摘要

94.  Fonseca PL, Rigamonti D, Miller NR, et al. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol. 2014 Oct;98(10):1360-3.

• 摘要

95.  Huang LC, Winter TW, Herro AM, et al. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension. J Neuroophthalmol. 2014 Sep;34(3):223-8.

• 摘要

96.  Niotakis G, Grigoratos D, Chandler C, et al. CSF diversion in refractory idiopathic intracranial hypertension: single-centre experience and review of efficacy. Childs Nerv Syst. 2013 Feb;29(2):263-7.

• 摘要

97.  Rizzo JL, Lam KV, Wall M, et al. Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2015 Mar;35(1):22-5.

• 摘要

98.  Wall M, Johnson CA, Kutzko KE, et al. Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects. Arch Ophthalmol. 1998 Jan;116(1):53-61.

• 摘要

99.  Verplanck M, Kaufman DI, Parsons T, et al. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri. Neurology. 1988 Nov;38(11):1789-92.

• 摘要

100.  ClinicalTrials.gov. Surgical Idiopathic Intracranial Hypertension Treatment Trial (SIGHT). NCT03501966. August 2018 [internet publication].

• 全文

101.  Tang RA, Dorotheo EU, Schiffman JS, et al. Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Curr Neurol Neurosci Rep. 2004 Sep;4(5):398-409.

• 摘要

102.  Karmaniolou I, Petropoulos G, Theodoraki K. Management of idiopathic intracranial hypertension in parturients: anesthetic considerations. Can J Anaesth. 2011 Jul;58(7):650.

• 摘要

103.  Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937 Oct;106(4):492-513.

• 全文
• 摘要

104.  Bradshaw P. Benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1956 Feb;19(1):28-41.

• 全文
• 摘要

105.  Bulens C, De Vries WA, van Crevel H. Benign intracranial hypertension: a retrospective and follow-up study. J Neurol Sci. 1979 Feb;40(2-3):147-57.

• 摘要

106.  Weisberg LA. Benign intracranial hypertension. Medicine (Baltimore). 1975 May;54(3):197-207.

• 摘要

107.  Wilson DH, Gardner WJ. Benign intracranial hypertension with particular reference to its occurrence in fat young women. Can Med Assoc J. 1966 Jul 16;95(3):102-5.

• 全文
• 摘要

108.  Greer M. Benign intracranial hypertension. Pseudotumor cerebri. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. New York, NY: Elsevier; 1974:150-66.

109.  Davidoff LM. Pseudotumor cerebri: benign intracranial hypertension. Neurology. 1956 Sep;6(9):605-15.

• 摘要

110.  Kessler LA, Novelli PM, Reigel DH. Surgical treatment of benign intracranial hypertension: subtemporal decompression revisited. Surg Neurol. 1998 Jul;50(1):73-6.

• 摘要

111.  Johnston I, Paterson A. Benign intracranial hypertension - II: CSF pressure and circulation. Brain. 1974 Jun;97(2):301-12.

• 摘要

112.  Weisberg LA, Chutorian AM. Pseudotumor cerebri of childhood. Am J Dis Child. 1977;131:1243-1248.

• 摘要

113.  Ahmad S. Amiodarone and reversible benign intracranial hypertension. Cardiology. 1996;87:90.

• 摘要

114.  Gucer G, Vierenstein L. Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg. 1978 Aug;49(2):256-63.

• 摘要

115.  Friedman DI. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol. 2006;26:61-64.

• 摘要

116.  Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72:304-309.

• 摘要